Centessa Pharmaceuticals Stock (NASDAQ:CNTA), Quotes and News Summary

Q: What sector and industry does Centessa Pharmaceuticals (CNTA) operate in?

Centessa Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Centessa Pharmaceuticals Stock (NASDAQ: CNTA) stock price, news, charts, stock research, profile.

Open	$10.680
Close	-
Volume / Avg.	49.683K / 389.713K
Day Range	10.370 - 10.835
52 Wk Range	3.840 - 12.450
Market Cap	$1.081B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	2.35%
Days to Cover	6.67

Recent News

Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) fell sharply during Friday’s session following third-quarter results.

Avi Kapoor

SPS Commerce Posts Upbeat Results, Joins Masonite International, Impinj And Other Big Stocks Moving Higher On Friday

U.S. stocks traded mixed, with the Nasdaq Composite gaining around 100 points on Friday. Shares of SPS Commerce, Inc. (NASDAQ: SPSC) rose sharply during Friday’s session following upbeat results.

Avi Kapoor

IBM, ServiceNow, Lennox, Morningstar And Other Big Stocks Moving Higher On Thursday

U.S. stocks traded lower, with the Nasdaq Composite falling more than 90 points on Thursday. Here are some big stocks bucking the trend and recording gains in today’s session.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Oct 23

Nov 23

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Centessa Pharmaceuticals plc

Sector

Health Care

Industry

Biotechnology

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline asse...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Centessa Pharmaceuticals (CNTA) stock?

You can purchase shares of Centessa Pharmaceuticals (NASDAQ: CNTA) through any online brokerage.

View our list of the best stock brokerages.

Who are Centessa Pharmaceuticals's (CNTA) competitors?

Other companies in Centessa Pharmaceuticals’s space includes: Macrogenics (NASDAQ:MGNX), Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), Zentalis Pharma (NASDAQ:ZNTL) and Prothena Corp (NASDAQ:PRTA).

What is the target price for Centessa Pharmaceuticals (CNTA) stock?

The latest price target for Centessa Pharmaceuticals (NASDAQ: CNTA) was reported by BMO Capital on Monday, April 1, 2024. The analyst firm set a price target for 15.00 expecting CNTA to rise to within 12 months (a possible 39.15% upside). 10 analyst firms have reported ratings in the last year.

Current Stock Price for Centessa Pharmaceuticals (CNTA)?

The stock price for Centessa Pharmaceuticals (NASDAQ: CNTA) is $10.78 last updated April 17, 2024 at 4:20 PM EDT.

Does Centessa Pharmaceuticals (CNTA) pay a dividend?

There are no upcoming dividends for Centessa Pharmaceuticals.

When is Centessa Pharmaceuticals (NASDAQ:CNTA) reporting earnings?

Centessa Pharmaceuticals’s Q1 earnings are confirmed for Friday, May 10, 2024.

Is Centessa Pharmaceuticals (CNTA) going to split?

There is no upcoming split for Centessa Pharmaceuticals.

What sector and industry does Centessa Pharmaceuticals (CNTA) operate in?

Centessa Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-